Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children

标题
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
作者
关键词
-
出版物
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 138, Issue 6, Pages 1752-1755
出版商
Elsevier BV
发表日期
2016-08-23
DOI
10.1016/j.jaci.2016.07.015

向作者/读者发起求助以获取更多资源

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started